Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China

Objective Kidney disease has become a significant public health issue. Socioeconomic improvements and environmental changes in China have influenced the kidney disease spectrum. This study aims to examine the changing spectrum of biopsy-confirmed kidney diseases in a single center from southeastern...

Full description

Saved in:
Bibliographic Details
Main Authors: Zishan Lin, Shidong Xie, Wenfeng Wang, Tao Hong, Bingjing Jiang, Caiming Chen, Xuan Tao, Dewen Jiang, Jianxin Wan, Hong Chen, Yanfang Xu
Format: Article
Language:English
Published: PeerJ Inc. 2025-04-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/19302.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698770798772224
author Zishan Lin
Shidong Xie
Wenfeng Wang
Tao Hong
Bingjing Jiang
Caiming Chen
Xuan Tao
Dewen Jiang
Jianxin Wan
Hong Chen
Yanfang Xu
author_facet Zishan Lin
Shidong Xie
Wenfeng Wang
Tao Hong
Bingjing Jiang
Caiming Chen
Xuan Tao
Dewen Jiang
Jianxin Wan
Hong Chen
Yanfang Xu
author_sort Zishan Lin
collection DOAJ
description Objective Kidney disease has become a significant public health issue. Socioeconomic improvements and environmental changes in China have influenced the kidney disease spectrum. This study aims to examine the changing spectrum of biopsy-confirmed kidney diseases in a single center from southeastern China and explore their clinical-pathological correlations. Methods Patients who underwent renal biopsy at the First Affiliated Hospital of Fujian Medical University from January 2010 to December 2023 were included in this retrospective study. Clinicopathological data were collected and analyzed. Results 2,832 patients were enrolled. Primary glomerular diseases accounted for the majority of kidney diseases (69.0%), followed by secondary glomerular diseases, tubulointerstitial diseases, and others. Among primary glomerular diseases, membranous nephropathy (MN) was the most prevalent (34.9%), followed closely by IgA nephropathy (IgAN) (34.5%) and minimal change disease (18.5%), with an increasing trend for MN. For secondary glomerular diseases, lupus nephritis (34.3%), diabetic nephropathy (DN) (24.8%), and hepatitis B virus-associated nephropathy (HBVN) (9.0%) were the most common. HBVN showed a significant decrease, while DN increased annually. Nephrotic syndrome (NS) was the most frequent indication for renal biopsy (40.3%), followed by progressive chronic kidney disease (22.4%). MN (47.2%) was the leading pathology in NS, and IgAN (51.6%) was predominant in patients with proteinuria and hematuria. Conclusions The spectrum of kidney disease has changed within the last 14 years. The relative frequency of MN and DN increased significantly, while that of HBVN decreased significantly. These findings highlight the need for ongoing public health efforts tailored to the changing spectrum of kidney diseases.
format Article
id doaj-art-7b4df0f0e5df49588b1c75f1ea416ebc
institution DOAJ
issn 2167-8359
language English
publishDate 2025-04-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj-art-7b4df0f0e5df49588b1c75f1ea416ebc2025-08-20T03:18:49ZengPeerJ Inc.PeerJ2167-83592025-04-0113e1930210.7717/peerj.19302Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast ChinaZishan Lin0Shidong Xie1Wenfeng Wang2Tao Hong3Bingjing Jiang4Caiming Chen5Xuan Tao6Dewen Jiang7Jianxin Wan8Hong Chen9Yanfang Xu10Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Pathology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Pathology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaDepartment of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, ChinaObjective Kidney disease has become a significant public health issue. Socioeconomic improvements and environmental changes in China have influenced the kidney disease spectrum. This study aims to examine the changing spectrum of biopsy-confirmed kidney diseases in a single center from southeastern China and explore their clinical-pathological correlations. Methods Patients who underwent renal biopsy at the First Affiliated Hospital of Fujian Medical University from January 2010 to December 2023 were included in this retrospective study. Clinicopathological data were collected and analyzed. Results 2,832 patients were enrolled. Primary glomerular diseases accounted for the majority of kidney diseases (69.0%), followed by secondary glomerular diseases, tubulointerstitial diseases, and others. Among primary glomerular diseases, membranous nephropathy (MN) was the most prevalent (34.9%), followed closely by IgA nephropathy (IgAN) (34.5%) and minimal change disease (18.5%), with an increasing trend for MN. For secondary glomerular diseases, lupus nephritis (34.3%), diabetic nephropathy (DN) (24.8%), and hepatitis B virus-associated nephropathy (HBVN) (9.0%) were the most common. HBVN showed a significant decrease, while DN increased annually. Nephrotic syndrome (NS) was the most frequent indication for renal biopsy (40.3%), followed by progressive chronic kidney disease (22.4%). MN (47.2%) was the leading pathology in NS, and IgAN (51.6%) was predominant in patients with proteinuria and hematuria. Conclusions The spectrum of kidney disease has changed within the last 14 years. The relative frequency of MN and DN increased significantly, while that of HBVN decreased significantly. These findings highlight the need for ongoing public health efforts tailored to the changing spectrum of kidney diseases.https://peerj.com/articles/19302.pdfKidney diseaseRenal biopsyMembranous nephropathyDiabetic nephropathyNephrotic syndrome
spellingShingle Zishan Lin
Shidong Xie
Wenfeng Wang
Tao Hong
Bingjing Jiang
Caiming Chen
Xuan Tao
Dewen Jiang
Jianxin Wan
Hong Chen
Yanfang Xu
Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
PeerJ
Kidney disease
Renal biopsy
Membranous nephropathy
Diabetic nephropathy
Nephrotic syndrome
title Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
title_full Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
title_fullStr Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
title_full_unstemmed Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
title_short Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
title_sort changes in the spectrum of kidney diseases a 14 year single center retrospective renal biopsy study from southeast china
topic Kidney disease
Renal biopsy
Membranous nephropathy
Diabetic nephropathy
Nephrotic syndrome
url https://peerj.com/articles/19302.pdf
work_keys_str_mv AT zishanlin changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT shidongxie changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT wenfengwang changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT taohong changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT bingjingjiang changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT caimingchen changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT xuantao changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT dewenjiang changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT jianxinwan changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT hongchen changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina
AT yanfangxu changesinthespectrumofkidneydiseasesa14yearsinglecenterretrospectiverenalbiopsystudyfromsoutheastchina